Neuroprotective effects of enriched environment in MPTP-treated SAMP8 mice

Neuroscience Letters

Volumn 454, Issue 1, 2009, Pages 6-10

  Yuan, Zhen Yun ^a   Gu, Ping ^a   Liu, Li ^a   Wang, Yan Yong ^a   Liu, Jing ^a   Cui, Dong Sheng ^a   Geng, Yuan ^a   Zhang, Zhong Xia ^a   Zhu, Ai Ping ^a   Ma, Lin ^a   Wang, Ming Wei ^a  

^a HEBEI MEDICAL UNIVERSITY   (China)

Author keywords

Enriched environment; MPTP; Parkinson's disease; SAMP8

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; DOPAMINE TRANSPORTER; TYROSINE 3 MONOOXYGENASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BEHAVIOR CHANGE; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; FEMALE; IMMUNOREACTIVITY; MOUSE; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; PARKINSONISM; PRIORITY JOURNAL; PROTEIN EXPRESSION; SUBSTANTIA NIGRA;

ANIMALS; BEHAVIOR, ANIMAL; BRAIN; CELL COUNT; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; ENVIRONMENT; FEMALE; IMMUNOHISTOCHEMISTRY; MICE; NERVE DEGENERATION; NEURONS; PARKINSONIAN DISORDERS;

EID: 62349099043     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2009.02.058     Document Type: Article

References (19)

1. Benaroya-Milshtein N., Hollander N., and Apter A. Environmental enrichment in mice decreases anxiety, attenuates stress responses and enhances natural killer cell activity. Eur. J. Neurosci. 20 (2004) 1341-1347
2. Bezard E., Dovero S., and Belin D. Enriched environment confers resistance to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and cocaine: involvement of dopamine transporter and trophic factors. J. Neurosci. 23 (2003) 10999-11007
3. Bezard E., Gross C.E., and Fournier M.C. Absence of MPTP-induced neuronal death in mice lacking the dopamine transporter. Exp. Neurol. 155 (1999) 268-273
4. Boyd J.D., Jang H., and Shepherd K.R. Response to 1-methyl-4-phenyl-1,2,3,6-tetrahydropy ridine (MPTP) differs in mouse strains and reveals a divergence in JNK signaling and COX-2 induction prior to loss of neurons in the substantia nigra pars compacta. Brain Res. 1175 (2007) 107-116
5. Colas D., Gharib A., and Bezin L. Regional age-related changes in neuronal nitric oxide synthase (nNOS), messenger RNA levels and activity in SAMP8 brain. BMC Neurosci. 21 (2006) 81-87
6. Collier T.J., Lipton J., and Daley B.F. Aging-related changes in the nigrostriatal dopamine system and the response to MPTP in nonhuman primates: diminished compensatory mechanisms as a prelude to Parkinsonism. Neurobiol. Dis. 26 (2007) 56-65
7. Donovan D.M., Miner L.L., and Perry M.P. Cocaine reward and MPTP toxicity: alteration by regional variant dopamine transporter overexpression. Mol. Brain Res. 73 (1999) 37-49
8. Fisher B.E., Petzinger G.M., and Nixon K. Exercise-induced behavioral recovery and neuroplasticity in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned mouse basal ganglia. J. Neurosci. Res. 77 (2004) 378-390
9. Hamilton D.A., and Kolb B. Differential effects of nicotine and complex housing of subsequent experience-dependent structural plasticity in the nucleus accumbens. Behav. Neurosci. 119 (2005) 355-365
10. Jackson-Lewis V., and Przedborski S. Protocol for the MPTP mouse model of Parkinson's disease. Nat. Protoc. 2 (2007) 141-151
11. Kopin I.J. Features of the dopaminergic neurotoxin MPTP. Ann. N Y Acad. Sci. 648 (1992) 96-104
12. Laviola G., Hannan A.J., and Macrì S. Effects of enriched environment on animal models of neurodegenerative diseases and psychiatric disorders. Neurobiol. Dis. 31 (2008) 159-168
13. Liu J., Wang Y.Y., and Liu L. Damage to the nigrostriatal system in the MPTP-treated SAMP8 mouse. Neurosci. Lett. 26 (2008) 184-188
14. Melrose H.L., Lincoln S.J., and Tyndall G.M. Parkinson's disease: a rethink of rodent models. Exp. Brain Res. 173 (2006) 196-204
15. Mohammed A.H., Zhu S.W., and Darmopil S. Environmental enrichment and the brain. Prog. Brain Res. 138 (2002) 109-133
16. Nithianantharajah J., and Hannan A.J. Enriched environments, experience-dependent plasticity and disorders of the nervous system. Nat. Rev. Neurosci. 7 (2006) 697-709
17. Schmidt N., and Ferger B. Neurochemical findings in the MPTP model of Parkinson's disease. J. Neural. Transm. 108 (2001) 1263-1282
18. van der Wee N.J., van Veen J.F., and Stevens H. Increased serotonin and dopamine transporter binding in psychotropic medication-naive patients with generalized social anxiety disorder shown by 123I-beta-(4-iodophenyl)-tropane SPECT. J. Nucl. Med. 49 (2008) 757-763
19. Yuan Z.Y., Gu P., and Ji W.Q. Effects of MPTP on spatial learning and memory ability and dopaminergic neurons in Nigra of senescence accelerated prone8 mice. Acad. J. Second Military Medical University 11 (2008) 1337-1340